<?xml version="1.0" encoding="UTF-8"?>

<ActivityDefinition xmlns="http://hl7.org/fhir">
  <id value="TherapeuticAnticoagulationUFH"/>
  <meta>
    <profile value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/drug-administration-action"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ActivityDefinition TherapeuticAnticoagulationUFH</b></p><a name="TherapeuticAnticoagulationUFH"> </a><a name="hcTherapeuticAnticoagulationUFH"> </a><a name="TherapeuticAnticoagulationUFH-en-US"> </a><p><b>url</b>: <a href="ActivityDefinition-TherapeuticAnticoagulationUFH.html">ActivityDefinition Therapeutic Anticoagulation Treatment UFH</a></p><p><b>version</b>: 0.1</p><p><b>name</b>: TherapeuticAnticoagulationPlanUFH</p><p><b>title</b>: Therapeutic Anticoagulation Treatment UFH</p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <span title="Codes:{http://hl7.org/fhir/fhir-types Patient}">Patient</span></p><p><b>date</b>: 2024-08-07 14:55:39+0000</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>Therapeutic Anticoagulation Treatment (UFH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l)</p>
</div><p><b>kind</b>: MedicationRequest</p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>product</b>: <span title="Codes:{http://snomed.info/sct 372877000}, {http://fhir.de/CodeSystem/bfarm/atc B01AB01}">Heparin (substance)</span></p><blockquote><p><b>dosage</b></p></blockquote></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel">
    <valueCode value="structured"/>
  </extension>
  <url value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-UFH-administration"/>
  <version value="0.1"/>
  <name value="TherapeuticAnticoagulationPlanUFH"/>
  <title value="Therapeutic Anticoagulation Treatment UFH"/>
  <status value="active"/>
  <experimental value="true"/>
  <subjectCodeableConcept>
    <coding>
      <system value="http://hl7.org/fhir/fhir-types"/>
      <code value="Patient"/>
    </coding>
  </subjectCodeableConcept>
  <date value="2024-08-07T14:55:39+00:00"/>
  <publisher value="NUM CODEX+ CELIDA"/>
  <description value="Therapeutic Anticoagulation Treatment (UFH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer &gt;= 2mg/l)"/>
  <kind value="MedicationRequest"/>
  <code>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="432102000"/>
      <display value="Administration of substance (procedure)"/>
    </coding>
  </code>
  <productCodeableConcept>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="372877000"/>
      <display value="Heparin (substance)"/>
    </coding>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <code value="B01AB01"/>
      <display value="Heparin"/>
    </coding>
  </productCodeableConcept>
  <dosage>
    <timing>
      <repeat>
        <frequency value="1"/>
        <period value="1"/>
        <periodUnit value="d"/>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="47625008"/>
        <display value="Intravenous route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <doseRange>
        <low>
          <value value="0"/>
          <unit value="IU"/>
          <system value="http://unitsofmeasure.org"/>
          <code value="[iU]"/>
        </low>
      </doseRange>
    </doseAndRate>
  </dosage>
</ActivityDefinition>